GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeMD Inc (NAS:LFMD) » Definitions » Enterprise Value

LifeMD (LifeMD) Enterprise Value : $312.8 Mil (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is LifeMD Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, LifeMD's Enterprise Value is $312.8 Mil. LifeMD's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-17.5 Mil. Therefore, LifeMD's EV-to-EBIT ratio for today is -17.89.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, LifeMD's Enterprise Value is $312.8 Mil. LifeMD's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-10.2 Mil. Therefore, LifeMD's EV-to-EBITDA ratio for today is -30.80.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, LifeMD's Enterprise Value is $312.8 Mil. LifeMD's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $163.6 Mil. Therefore, LifeMD's EV-to-Revenue ratio for today is 1.91.


LifeMD Enterprise Value Historical Data

The historical data trend for LifeMD's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeMD Enterprise Value Chart

LifeMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.73 145.71 82.03 65.27 304.99

LifeMD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.89 150.43 223.05 304.99 404.60

Competitive Comparison of LifeMD's Enterprise Value

For the Health Information Services subindustry, LifeMD's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeMD's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's Enterprise Value distribution charts can be found below:

* The bar in red indicates where LifeMD's Enterprise Value falls into.



LifeMD Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

LifeMD's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

LifeMD's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeMD  (NAS:LFMD) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

LifeMD's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=312.751/-17.482
=-17.89

LifeMD's current Enterprise Value is $312.8 Mil.
LifeMD's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.5 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

LifeMD's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=312.751/-10.154
=-30.80

LifeMD's current Enterprise Value is $312.8 Mil.
LifeMD's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.2 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

LifeMD's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=312.751/163.565
=1.91

LifeMD's current Enterprise Value is $312.8 Mil.
LifeMD's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $163.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeMD Enterprise Value Related Terms

Thank you for viewing the detailed overview of LifeMD's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeMD (LifeMD) Business Description

Traded in Other Exchanges
N/A
Address
236 Fifth Avenue, Suite 400, Fourth Floor, New York, NY, USA, 10001
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Executives
Bertrand Velge director BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
William J Febbo director, other: Consultant 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Nicholas P Alvarez officer: Chief Acquisition Officer C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Eric Harold Yecies officer: CCO and General Counsel C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Brad Michael Roberts officer: Chief Operating Officer 300 CHAFFORD COURT, SIMPSONVILLE SC 29681
Justin Schreiber director, 10 percent owner, officer: President, Immudyne PR 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Stefan Galluppi director, officer: Chief Operating Officer C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joan Larovere director C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Jessica Friedeman officer: Chief Marketing Officer C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Kathleen E Walsh director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Piyush Jindal director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joseph Ditrolio director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Maria E. Stan officer: Principal Accounting Officer 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Dennis Wijnker officer: Chief Technology Officer 536 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Naveen Bhatia director 823 GREENTREE RD, PACIFIC PALISADES CA 90272